Increased Mortality Associated with Hypermagnesemia in Severe COVID-19 Illness

被引:18
|
作者
Stevens, Jacob S. [1 ,2 ]
Moses, Andrew A. [1 ]
Nickolas, Thomas L. [1 ,2 ]
Husain, Syed Ali [1 ,2 ]
Mohan, Sumit [1 ,2 ,3 ]
机构
[1] Columbia Univ, Irving Med Ctr, Div Nephrol, Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10032 USA
[3] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA
来源
KIDNEY360 | 2021年 / 2卷 / 07期
关键词
acid; base and electrolyte disorders; coronavirus; COVID-19; hypermagnesemia; magnesium; rhabdomyolysis; SARS-CoV-2; MAGNESIUM;
D O I
10.34067/KID.0002592021
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Although electrolyte abnormalities are common among patients with COVID-19, very little has been reported on magnesium homeostasis in these patients. Here we report the incidence of hypermagnesemia, and its association with outcomes among patients admitted with COVID-19. Methods We retrospectively identified all patients with a positive test result for SARS-CoV-2 who were admitted to a large quaternary care center in New York City in spring 2020. Details of the patients' demographics and hospital course were obtained retrospectively from medical records. Patients were defined as having hypermagnesemia if their median magnesium over the course of their hospitalization was > 2.4 mg/dl. Results A total of 1685 patients hospitalized with COVID-19 had their magnesium levels checked during their hospitalization, and were included in the final study cohort, among whom 355 (21%) had hypermagnesemia. Patients who were hypermagnesemic had a higher incidence of shock requiring pressors (35% vs 27%, P < 0.01),respiratory failure requiring mechanical ventilation (28% vs 21%, =50.01), AKI (65% vs 50%, P < 0.001), and AKI severe enough to require renal replacement therapy (18% vs 5%, P < 0.001). In an adjusted multivariable model, hypermagnesemia was observed more commonly with increasing age, male sex, AKI requiring RRT, hyperkalemia, and higher CPK. Survival probability at 30 days was 34% for the patients with hypermagnesemia, compared with65% for patients without hypermagnesemia. An adjusted multivariable time to event analysis identified an in creased risk of mortality with older age, need for vasopressors, higher C-reactive protein levels, and hypermagnesemia (HR, 2.03; 95% CI, 1.63 to 2.54, P < 0.001). Conclusions In conclusion, we identified an association between hypermagnesemia among patients hospitalized with COVID-19 and increased mortality. Although the exact mechanism of this relationship remains unclear, hypermagnesemia potentially represents increased cell turnover and higher severity of illness, which is frequently associated with more severe forms of AKI.
引用
收藏
页码:1087 / 1094
页数:8
相关论文
共 50 条
  • [1] Severe mental illness is associated with increased mortality and severe course of COVID-19
    Barcella, Carlo Alberto
    Polcwiartek, Christoffer
    Mohr, Grimur Hognason
    Hodges, Gethin
    Sondergaard, Kathrine
    Niels Bang, Casper
    Andersen, Mikkel Porsborg
    Fosbol, Emil
    Kober, Lars
    Schou, Morten
    Torp-Pedersen, Christian
    Kessing, Lars Vedel
    Gislason, Gunnar
    Kragholm, Kristian
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2021, 144 (01) : 82 - 91
  • [2] Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19
    Jin, Zhen-Mu
    Shi, Ji-Chan
    Zheng, Mo
    Chen, Que-Lu
    Zhou, Yue-Ying
    Cheng, Fang
    Cai, Jing
    Jiang, Xian-Gao
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (01) : 128 - 135
  • [3] Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19
    Zhen-Mu Jin
    Ji-Chan Shi
    Mo Zheng
    Que-Lu Chen
    Yue-Ying Zhou
    Fang Cheng
    Jing Cai
    Xian-Gao Jiang
    [J]. World Journal of Clinical Cases, 2022, (01) : 128 - 135
  • [4] Vaping and subsequent comorbidities potentially associated with increased mortality and more severe illness in COVID-19: a narrative review
    Blalock, Kyle
    Breve, Frank
    Varrassi, Giustino
    Magnusson, Peter
    Pergolizzi, Joseph
    [J]. SIGNA VITAE, 2021, 17 (06): : 25 - 36
  • [5] Antithrombin Activity is Associated with Persistent Thromboinflammation and Mortality in Patients with Severe COVID-19 Illness
    Chen-Goodspeed, Amber
    Dronavalli, Goutham
    Zhang, Xu
    Podbielski, Jeanette M.
    Patel, Bela
    Modis, Katalin
    Cotton, Bryan A.
    Wade, Charles E.
    Cardenas, Jessica C.
    [J]. ACTA HAEMATOLOGICA, 2023, 146 (02) : 117 - 124
  • [6] COVID-19 during pregnancy: increased risk of severe illness
    不详
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2022, 217 (05) : 223 - 223
  • [7] Complement dysregulation is associated with severe COVID-19 illness
    Yu, Jia
    Gerber, Gloria F.
    Chen, Hang
    Yuan, Xuan
    Chaturvedi, Shruti
    Braunstein, Evan M.
    Brodsky, Robert A.
    [J]. HAEMATOLOGICA, 2022, 107 (05) : 1095 - 1105
  • [8] MYOCARDIAL INJURY IS NOT ASSOCIATED WITH MORTALITY IN SEVERE COVID-19
    O'Brien, Connor G.
    Ashland, Melanie
    Chang, Donald D.
    Morin, Daniel P.
    Kapil, Shikha
    Barnett, Christopher F.
    Khanijo, Sameer
    Stavi, Dekel
    Goffi, Alberto
    Fiza, Babar
    Patterson, Andrew
    Carrier, Francois Martin
    Daubert, Thomas
    Castellucci, Clara
    Thompson, Shaun
    Bughrara, Nibras
    Zekhtser, Mitchell
    Courchesne, Karl
    Mayette, Michael
    Parikh, Rushi
    Mohabir, Paul
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 641 - 641
  • [9] Hypozincemia in the early stage of COVID-19 is associated with an increased risk of severe COVID-19
    Fromonot, Julien
    Gette, Mickael
    Ben Lassoued, Amin
    Gueant, Jean-Louis
    Gueant-Rodriguez, Rosa-Maria
    Guieu, Regis
    [J]. CLINICAL NUTRITION, 2022, 41 (12) : 3115 - 3119
  • [10] Pregnant Women at Increased Risk of Severe Illness From COVID-19
    不详
    [J]. US PHARMACIST, 2022, 47 (09) : 30 - 31